Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9295657 | PAR STERILE PRODUCTS | Epinephrine formulations |
Mar, 2035
(11 years from now) | |
US9119876 | PAR STERILE PRODUCTS | Epinephrine formulations |
Mar, 2035
(11 years from now) | |
US10130592 | PAR STERILE PRODUCTS | Epinephrine formulations |
Mar, 2035
(11 years from now) |
Adrenalin is owned by Par Sterile Products.
Adrenalin contains Epinephrine.
Adrenalin has a total of 3 drug patents out of which 0 drug patents have expired.
Adrenalin was authorised for market use on 07 December, 2012.
Adrenalin is available in solution;intramuscular, intravenous, subcutaneous dosage forms.
Adrenalin can be used as emergency treatment of allergic reactions (type i), including anaphylaxis.
The generics of Adrenalin are possible to be released after 13 March, 2035.
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 07 December, 2012
Treatment: Emergency treatment of allergic reactions (type i), including anaphylaxis
Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic